Gufic Biosciences Limited — Teicoplanin Exporter Profile
Indian Pharmaceutical Exporter · #1 for Teicoplanin · $4.3M export value · DGFT Verified
Gufic Biosciences Limited is the #1 Indian exporter of Teicoplanin with $4.3M in export value and 87 verified shipments. Gufic Biosciences Limited holds a 69.2% market share in Teicoplanin exports across 8 countries. The company exports 5 pharmaceutical products worth $12.6M across 4 therapeutic categories.
Gufic Biosciences Limited — Teicoplanin Export Profile: Buyers & Destinations
Where Does Gufic Biosciences Limited Export Teicoplanin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| SRI LANKA | $749.2K | 30 | 40.3% |
| HUNGARY | $506.7K | 23 | 27.2% |
| SOUTH AFRICA | $316.4K | 10 | 17.0% |
| GERMANY | $175.6K | 7 | 9.4% |
| MALAYSIA | $50.0K | 1 | 2.7% |
| KENYA | $35.4K | 6 | 1.9% |
| NEPAL | $28.0K | 3 | 1.5% |
| BULGARIA | $87 | 7 | 0.0% |
Gufic Biosciences Limited exports Teicoplanin to 8 countries. The largest destination is SRI LANKA accounting for 40.3% of Gufic Biosciences Limited's Teicoplanin shipments, followed by HUNGARY (27.2%) and SOUTH AFRICA (17.0%). These destinations reflect Gufic Biosciences Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Teicoplanin from Gufic Biosciences Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| TO THE ORDER OF | SRI LANKA | $623.7K | 36 |
| SLIM PHARMACEUTICALS (PVT) LTD, | SRI LANKA | $239.1K | 14 |
| AUSTELL PHARMACEUTICALS (PTY) LTD, | SOUTH AFRICA | $133.0K | 4 |
| HANSE SERVICE INTERNATIONALE | GERMANY | $131.2K | 3 |
| HATTON NATIONAL BANK PLC, | SRI LANKA | $110.5K | 3 |
| PEOPLE'S BANK, | SRI LANKA | $100.0K | 2 |
| BANK OF CEYLON | SRI LANKA | $94.5K | 4 |
| AUSTELL PHARMACEUTICALS ( PTY) LTD | SOUTH AFRICA | $67.3K | 3 |
| AUSTELL PHARMACEUTICALS ( PTY) LIMITED | SOUTH AFRICA | $66.1K | 2 |
| SLIM PHARMACEUTICALS PVT LTD | SRI LANKA | $50.0K | 1 |
Gufic Biosciences Limited supplies Teicoplanin to 19 buyers globally. The largest buyer is TO THE ORDER OF (SRI LANKA), followed by SLIM PHARMACEUTICALS (PVT) LTD, (SRI LANKA) and AUSTELL PHARMACEUTICALS (PTY) LTD, (SOUTH AFRICA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Teicoplanin Export Value and How Much Does Gufic Biosciences Limited Contribute?
India exported $5.7M worth of Teicoplanin through 310 shipments from 60 suppliers to 44 countries, serving 108 buyers globally. Gufic Biosciences Limited contributes $4.3M to this total, accounting for 69.2% of India's Teicoplanin exports. Gufic Biosciences Limited ships Teicoplanin to 8 countries through 19 buyers.
What Is the Average Shipment Value for Gufic Biosciences Limited's Teicoplanin Exports?
Gufic Biosciences Limited's average Teicoplanin shipment value is $50.0K per consignment, based on 87 shipments totaling $4.3M. The largest destination is SRI LANKA (40.3% of Gufic Biosciences Limited's Teicoplanin exports).
How Does Gufic Biosciences Limited Compare to Other Indian Teicoplanin Exporters?
Gufic Biosciences Limited ranks #1 among 60 Indian Teicoplanin exporters with a 69.2% market share. The top 3 exporters are GUFIC BIOSCIENCES LIMITED ($4.3M), FLAGSHIP BIOTECH INTERNATIONAL PRIVATE LIMITED ($250.0K), JODAS EXPOIM PRIVATE LIMITED ($250.0K). Gufic Biosciences Limited processed 87 shipments to 8 destination countries.
What Teicoplanin Formulations Does Gufic Biosciences Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| TICPLAT 200 INJ (TEICOPLANIN FOR INJ 200 | $110.5K | 3 |
| TEGORID IV 400 (TEICOPLANIN 400 mg INJ) | $100.0K | 2 |
| TICPLAT 400 INJ (TEICOPLANIN FOR INJ 400 | $100.0K | 2 |
| TICPLAT 400(TEICOPLANIN FOR INJ 400 mg) | $99.8K | 6 |
| TICPLAT 200 INJ TEICOPLANIN FOR INJ 200MG 28110 VIALS | $50.0K | 1 |
| TEICOPLANIN EBERTH 400 MG PACK SIZE 1X1 S VLS 24000 VLS | $50.0K | 1 |
| TICPLAT 400 (TEICOPLANIN FOR INJ 400 MG)(8000 VIALS) | $50.0K | 1 |
| TICPLAT 200 (TEICOPLANIN FOR INJ 200 MG)(20000 VIALS) | $50.0K | 1 |
| TICPLAT 200 INJ (TEICOPLANIN 200 mg POWDER FOR SOLUTION FOR INJECTION INFUSION)(15216 VIALS) | $50.0K | 1 |
| TEICOPLANIN FOR INJECTION 400 MG (TEGORID IV 400 ), 64420 VIALS, PACK SIZE- ( 1X1'S ) | $50.0K | 1 |
Gufic Biosciences Limited exports 68 distinct Teicoplanin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is TICPLAT 200 INJ (TEICOPLANIN FOR INJ 200 with 3 shipments worth $110.5K.
Regulatory Requirements: Exporting Teicoplanin to Key Markets
What Gufic Biosciences Limited must comply with to export Teicoplanin to its top destination countries
South Africa — SAHPRA
Approval Process
Registration under SAHPRA guidelines (CTD format). Bioequivalence required for generics.
Timeline: 24–48 months (significant backlog)
GMP & Export Requirements
WHO GMP or PIC/S GMP compliance
Certificate of Pharmaceutical Product from CDSCO; Import permit per Section 22A of Medicines Act
Note: Known registration backlog. WHO Prequalification significantly assists the process.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Gufic Biosciences Limited Compare to Nearest Teicoplanin Exporters?
Exporters ranked immediately above and below #1 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | GUFIC BIOSCIENCES LIMITED ★ | $4.3M | 87 | 8 | $50.0K |
| 2 | FLAGSHIP BIOTECH INTERNATIONAL PRIVATE LIMITED | $250.0K | 5 | 3 | $50.0K |
| 3 | JODAS EXPOIM PRIVATE LIMITED | $250.0K | 5 | 1 | $50.0K |
Gufic Biosciences Limited ranks #1 among 60 Indian Teicoplanin exporters. Average shipment value of $50.0K compared to the market average of $95.7K. The closest competitors by value are FLAGSHIP BIOTECH INTERNATIONAL PRIVATE LIMITED and JODAS EXPOIM PRIVATE LIMITED.
Which Indian Ports Ship Teicoplanin Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 69 | 22.3% |
| SAHAR AIR | 67 | 21.6% |
| NHAVA SHEVA SEA (INNSA1) | 27 | 8.7% |
| DELHI AIR | 24 | 7.7% |
| Bombay Air | 22 | 7.1% |
| DELHI AIR CARGO ACC (INDEL4) | 16 | 5.2% |
| CHENNAI AIR CARGO ACC (INMAA4) | 8 | 2.6% |
| HYDERABAD AIR | 8 | 2.6% |
What Other Advanced Antibiotics Products Does Gufic Biosciences Limited Export?
Gufic Biosciences Limited also exports these advanced antibiotics products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Gufic Biosciences Limited's Teicoplanin Exports
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Gufic Biosciences. The Israel-Iran conflict has led to increased tensions in the Red Sea, a vital shipping route for Indian exports. Houthi attacks in the region have disrupted maritime logistics, resulting in higher shipping costs and potential delays. These disruptions could impact Gufic's supply chain efficiency and delivery timelines, necessitating strategic adjustments to maintain export commitments.
In the United States, recent tariff policies have introduced uncertainties for pharmaceutical imports. While health products have been exempt from tariffs, there have been threats to impose significant increases to encourage domestic production. Such measures could affect Indian exporters, including Gufic, by altering the competitive landscape and potentially reducing market share in the U.S. (lemonde.fr)
Conversely, U.S.-China trade tensions have opened avenues for Indian pharmaceutical companies to fill gaps left by Chinese suppliers. Gufic could leverage this opportunity to expand its footprint in markets seeking alternative sources for pharmaceutical products.
In the European Union, compliance with the Falsified Medicines Directive (FMD) remains a critical requirement for exporters. The directive mandates stringent serialization and traceability measures to prevent counterfeit medicines from entering the supply chain. Gufic's adherence to these regulations is essential to maintain and grow its presence in the EU market.
Gufic Biosciences Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. Gufic's Indore facility, which commenced production in October 2024, is designed to meet WHO GMP, EU GMP, ANVISA, MHRA, and USFDA standards. This facility has achieved 30% capacity utilization for FY26 and is on track for EBITDA breakeven. Such compliance not only facilitates market access but also enhances the company's reputation for quality and reliability. (scanx.trade)
However, recent tax-related penalties highlight the importance of robust internal controls and adherence to financial regulations. Gufic's proactive approach in appealing these penalties demonstrates its commitment to regulatory compliance and financial integrity.
About Gufic Biosciences Limited
Gufic Biosciences Limited exports 5 products worth $12.6M. Beyond Teicoplanin, top products include Vancomycin, Strip, Meropenem, Amphotericin. View the complete Gufic Biosciences Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Teicoplanin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Teicoplanin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Gufic Biosciences Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 87 individual customs records matching Gufic Biosciences Limited exporting Teicoplanin, covering 68 formulations to 8 countries via 19 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 44+ countries, 108+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Teicoplanin Export Data from Gufic Biosciences Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Gufic Biosciences Limited's Teicoplanin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Gufic Biosciences Limited
Full Company Profile →
5 products · $12.6M total trade · 4 categories
Teicoplanin Stats
Company Overview
Top Products by Gufic Biosciences Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Gufic Biosciences Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Teicoplanin. For current shipment-level data, contact TransData Nexus.